The patent badge is an abbreviated version of the USPTO patent document. The patent badge does contain a link to the full patent document.

The patent badge is an abbreviated version of the USPTO patent document. The patent badge covers the following: Patent number, Date patent was issued, Date patent was filed, Title of the patent, Applicant, Inventor, Assignee, Attorney firm, Primary examiner, Assistant examiner, CPCs, and Abstract. The patent badge does contain a link to the full patent document (in Adobe Acrobat format, aka pdf). To download or print any patent click here.

Date of Patent:
Nov. 14, 2017

Filed:

Sep. 12, 2013
Applicant:

Japanese Foundation for Cancer Research, Tokyo, JP;

Inventors:

Kiyotaka Shiba, Tokyo, JP;

Katsutoshi Kokubun, Tokyo, JP;

Kanako Suga, Tokyo, JP;

Attorney:
Primary Examiner:
Int. Cl.
CPC ...
C07K 7/06 (2006.01); C07K 7/08 (2006.01); G01N 33/574 (2006.01); C07K 14/705 (2006.01); C07K 14/47 (2006.01); C07K 16/00 (2006.01); G01N 33/68 (2006.01);
U.S. Cl.
CPC ...
C07K 7/06 (2013.01); C07K 7/08 (2013.01); C07K 14/47 (2013.01); C07K 14/70596 (2013.01); C07K 16/005 (2013.01); G01N 33/574 (2013.01); G01N 33/6872 (2013.01); C07K 2319/00 (2013.01); C07K 2319/60 (2013.01); G01N 2333/70596 (2013.01);
Abstract

[Problem to be Solved] An object of the present invention is to provide a novel peptide that has the high ability to bind to EpCAM, which can be easily prepared by a chemical synthesis method or a genetic engineering method. [Solution] The present inventors have improved a method for screening a phage library and thereby successfully screened for a peptide that has the higher ability to bind to EpCAM compared with publicly known peptides. The present inventors have also used an already disclosed peptide having the ability to bind to EpCAM as a lead compound to prepare diverse populations of derivatives thereof, from among which a peptide strongly binding to EpCAM has been selected. The obtained peptides exhibit at least 10 times higher ability to bind to EpCAM compared with publicly known peptides and as such, are effective for the detection or diagnosis of cancer cells.


Find Patent Forward Citations

Loading…